Concepedia

Publication | Closed Access

Safety, Reactogenicity, and Immunogenicity of a Recombinant Protective Antigen Anthrax Vaccine Given to Healthy Adults

DOI

72

Citations

11

References

2007

Year

James D. Campbell, Kristin H. Clement, Steven A. Wasserman, Sarah Donegan, Lisa Chrisley, Karen L. Kotloff
Human Vaccines

Abstract

This recombinant Protective Antigen anthrax vaccine, when given with the adjuvant Alhydrogel to healthy adults in two intramuscular injections four weeks apart, is very well-tolerated and highly immunogenic.

References

YearCitations

Page 1